Thus, it is tempting to speculate that Ang II-mediated shedding of EGF-like ligands, subsequent transactivation of EGFR and activation of the pro-inflammatory NF-κB could be a likely mechanism in the development of GN–though this requires further study and verification in vivo. This evidence concerns the gene NFKB1 and ganglioneuroma.